Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6920787B2 - Sebum secretion promoter and its use - Google Patents
[go: Go Back, main page]

JP6920787B2 - Sebum secretion promoter and its use - Google Patents

Sebum secretion promoter and its use Download PDF

Info

Publication number
JP6920787B2
JP6920787B2 JP2015195252A JP2015195252A JP6920787B2 JP 6920787 B2 JP6920787 B2 JP 6920787B2 JP 2015195252 A JP2015195252 A JP 2015195252A JP 2015195252 A JP2015195252 A JP 2015195252A JP 6920787 B2 JP6920787 B2 JP 6920787B2
Authority
JP
Japan
Prior art keywords
extract
component
sebum secretion
added
sebum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015195252A
Other languages
Japanese (ja)
Other versions
JP2017066106A (en
Inventor
宗子 古林
宗子 古林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2015195252A priority Critical patent/JP6920787B2/en
Priority to PCT/JP2016/078547 priority patent/WO2017057420A1/en
Publication of JP2017066106A publication Critical patent/JP2017066106A/en
Application granted granted Critical
Publication of JP6920787B2 publication Critical patent/JP6920787B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、皮脂分泌促進剤及びその利用に関する。 The present invention relates to a sebum secretion promoter and its use.

皮脂にはトリグリセリド、ワックスエステル、スクアレン、遊離脂肪酸等が含まれている。このような皮脂は皮脂腺から分泌され、皮膚表面に柔軟性を与える、弾力性を与える、保湿性を保つといった作用を有している。また、皮脂は、紫外線等による皮膚表面の損傷を防ぐ、細菌等の異物から皮膚表面を保護するといった重要な役割を果たしている。 Sebum contains triglycerides, wax esters, squalene, free fatty acids and the like. Such sebum is secreted from the sebaceous glands and has actions such as giving flexibility to the skin surface, giving elasticity, and maintaining moisturizing properties. In addition, sebum plays an important role in preventing damage to the skin surface due to ultraviolet rays and the like, and protecting the skin surface from foreign substances such as bacteria.

一方、皮脂の分泌量は、加齢や薬物投与等の様々な要因により減ることが知られている。皮脂の分泌量の低下は、皮膚表面の柔軟性等が衰える、損傷等に対する皮膚表面の抵抗力が低下するといった悪影響を及ぼし、また、皮膚表面の乾燥や皮脂欠乏性湿疹といった皮膚疾患等の原因にもなる。従って、皮脂分泌を促進させることは重要である。 On the other hand, it is known that the amount of sebum secreted decreases due to various factors such as aging and drug administration. A decrease in the amount of sebum secreted has an adverse effect such as a decrease in the flexibility of the skin surface and a decrease in the resistance of the skin surface to damage, and also causes skin diseases such as dry skin surface and sebum deficiency eczema. It also becomes. Therefore, it is important to promote sebum secretion.

これまでに、マイタケの抽出物により皮脂の分泌が促進されることが報告されている(特許文献1)。 So far, it has been reported that the extract of Maitake mushroom promotes the secretion of sebum (Patent Document 1).

国際公開第2007/142130号International Publication No. 2007/142130

本発明は、皮脂分泌を効果的に促進できる皮脂分泌促進剤及び該皮脂分泌促進剤を含有する組成物等を提供することを目的とする。 An object of the present invention is to provide a sebum secretion-promoting agent capable of effectively promoting sebum secretion, a composition containing the sebum secretion-promoting agent, and the like.

本発明者が前記課題に鑑み鋭意研究を重ねたところ、センキュウの抽出物、クララの抽出物、フキタンポポの抽出物、フユボダイジュの抽出物、ブクリョウの抽出物、ラベンダーの抽出物を用いることによって、皮脂の分泌を向上できることを見出した。本発明は該知見に基づき更に検討を重ねた結果完成されたものであり、下記に掲げるものである。
項1.センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種の抽出物を含有する皮脂分泌促進剤。
項2.項1に記載する皮脂分泌促進剤を含有する、皮脂分泌促進用外用組成物。
項3.前記組成物中、センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種の抽出物を、抽出物の乾燥物換算で0.0001〜20重量%含有する、項2に記載の皮脂分泌促進用外用組成物。
As a result of intensive research conducted by the present inventor in view of the above problems, by using the extract of Senkyu, the extract of Clara, the extract of Fukitanpopo, the extract of Fuyubodaiju, the extract of Bukuryo, and the extract of lavender, It was found that the secretion of sebum can be improved. The present invention has been completed as a result of further studies based on the findings, and is as follows.
Item 1. A sebum secretagogue containing at least one extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and lavender.
Item 2. An external composition for promoting sebum secretion, which contains the sebum secretion promoting agent according to Item 1.
Item 3. The above-mentioned composition contains 0.0001 to 20% by weight of a dry extract of at least one extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and Lavender. 2. The external composition for promoting sebum secretion according to 2.

本発明によれば、皮脂の分泌を促進できる。このため、本発明によれば、皮脂分泌低下に伴う皮膚症状を改善できる。 According to the present invention, the secretion of sebum can be promoted. Therefore, according to the present invention, it is possible to improve the skin symptoms associated with the decrease in sebum secretion.

図1は、前記抽出物によって皮脂腺細胞中の脂肪滴が成長し、皮脂の分泌が促進されたことを示す。FIG. 1 shows that the extract caused the growth of lipid droplets in sebaceous gland cells and promoted the secretion of sebum.

皮脂分泌促進剤
本発明は、センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種の抽出物を含有する皮脂分泌促進剤を提供する。
Sebum Secretagogue The present invention provides a sebum secretagogue containing at least one extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and Lavender.

本発明の皮脂分泌促進剤に有効成分として含まれる前記抽出物の原料としては、センキュウ(Cnidium officinale)、クララ(Sophora flavescens)、フキタンポポ(Tussilago farfara)、フユボダイジュ(Tilia cordata)、ブクリョウ(Poria cocos)、ラベンダー(Lavandula)が挙げられる。 The raw materials for the extract contained as an active ingredient in the sebum secretion promoter of the present invention include Cnidium officinale, Sophora flavescens, Coltsfoot farfara, Tilia cordata, and Poria cocos. ), Lavandula.

これらの植物であれば、使用部位は特に限定されないが、好ましくはセンキュウの根茎、クララの根や根の周皮を除いたもの、フキタンポポの花、フユボダイジュの葉や花、ブクリョウの外層を取り除いた菌核、ラベンダーの花が例示される。 For these plants, the site of use is not particularly limited, but preferably, the rhizome of Senkyu, the root of Clara excluding the periderm of the root, the flower of Tilia cordata, the leaves and flowers of Tilia cordata, and the outer layer of Bukuryo are removed. Examples include rhizomes and lavender flowers.

本発明の皮脂分泌促進剤の有効成分として、前記抽出物を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。前記抽出物を2種以上組み合わせて使用する場合、これらの組み合わせは特に限定されず、また、その使用部位も限定されない。 As the active ingredient of the sebum secretion promoter of the present invention, the extract may be used alone or in combination of two or more. When two or more kinds of the extracts are used in combination, these combinations are not particularly limited, and the site of use thereof is not particularly limited.

また、前記植物はこの限りにおいて制限されず、前記植物には様々な呼び方が存在することも多く、例えばクララはクジン、Sophora flavescens var. angustifolia、Sophora Angustifoliaなどと表記される場合もあり、例えばフユボダイジュはシナノキなどと表記される場合もあり、本発明はこのような呼称の別も包含する。 In addition, the plant is not limited to this extent, and the plant is often referred to in various ways. For example, Clara may be described as Kujin, Sophora flavescens var. Angustifolia, Sophora Angustifolia, etc. Tilia cordata is sometimes referred to as linden or the like, and the present invention includes such names.

前記抽出物は、その製造方法(抽出方法)及び抽出条件等は特に限定されず、従来公知の方法に従えばよい。例えば、前記植物の各部位(全草、花、果実、葉、枝、樹皮、根茎、根、根の周皮を除いたもの、種子、種皮、菌核等)をそのまま、必要に応じて裁断、粉砕または乾燥等したのち、搾取または溶媒抽出によって抽出物を得ることができる。溶媒抽出の方法としては、該分野において公知の方法を採用すればよく、例えば水(温水、熱水を含む)抽出、アルコール抽出、超臨界抽出等の従来公知の抽出方法を利用することができる。 The production method (extraction method), extraction conditions, and the like of the extract are not particularly limited, and conventionally known methods may be followed. For example, each part of the plant (whole plant, flower, fruit, leaf, branch, bark, rhizome, root, root without periderm, seed, seed coat, sclerotium, etc.) is cut as it is as needed. After crushing or drying, the extract can be obtained by exploitation or solvent extraction. As the solvent extraction method, a method known in the art may be adopted, and conventionally known extraction methods such as water (including hot water and hot water) extraction, alcohol extraction, supercritical extraction and the like can be used. ..

溶媒抽出を行う場合、溶媒としては例えば水;メタノール、エタノール等の低級アルコールや、プロピレングリコール、1,3−ブチレングリコール等の多価アルコール等のアルコール類(無水、含水の別を問わない);アセトン等のケトン類、ジエチルエーテル、ジオキサン、アセトニトリル、酢酸エチルエステル等のエステル類、キシレン、ベンゼン、クロロホルム等が挙げられ、このようにして得られた抽出物を特に溶媒抽出物と称することができる。溶媒として好ましくは水、低級アルコール、1,3−ブチレングリコール等(水抽出物、低級アルコール抽出物、1,3−ブチレングリコール抽出物等)であり、より好ましくはエタノール(エタノール抽出物)、1,3−ブチレングリコール(1,3−ブチレングリコール抽出物)、更に好ましくは含水エタノール(含水エタノール抽出物)である。これらの溶媒は1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 When solvent extraction is performed, the solvent is, for example, water; lower alcohols such as methanol and ethanol, and alcohols such as polyhydric alcohols such as propylene glycol and 1,3-butylene glycol (whether anhydrous or water-containing); Examples thereof include ketones such as acetone, esters such as diethyl ether, dioxane, acetonitrile and ethyl acetate, xylene, benzene, chloroform and the like, and the extract thus obtained can be particularly referred to as a solvent extract. .. The solvent is preferably water, lower alcohol, 1,3-butylene glycol or the like (water extract, lower alcohol extract, 1,3-butylene glycol extract or the like), and more preferably ethanol (ethanol extract), 1 , 3-Butylene glycol (1,3-butylene glycol extract), more preferably hydrous ethanol (hydrous ethanol extract). These solvents may be used alone or in combination of two or more.

得られた抽出物は、そのままの状態で使用してもよく、乾燥させて粉末状や顆粒状等の固形の状態で使用してもよい。また、必要に応じて、得られた抽出物に精製、濃縮処理、高活性画分の分離処理等を施してもよい。本発明を制限するものではないが、精製処理としては、濾過又はイオン交換樹脂や活性炭カラム等を用いた吸着、脱色といった処理を利用できる。また、濃縮処理としては、エバポレーター等の常法を利用できる。また、高活性画分の分離処理としては、ゲル濾過、吸着処理、シリカゲルカラムクロマトグラフィー、HPLC(High performance liquid chromatography)等の公知の分離処理を利用できる。 The obtained extract may be used as it is, or may be dried and used in a solid state such as powder or granules. Further, if necessary, the obtained extract may be subjected to purification, concentration treatment, separation treatment of highly active fractions and the like. Although not limiting the present invention, as the purification treatment, treatments such as filtration or adsorption and decolorization using an ion exchange resin or an activated carbon column can be used. Further, as the concentration treatment, a conventional method such as an evaporator can be used. Further, as the separation treatment of the highly active fraction, known separation treatments such as gel filtration, adsorption treatment, silica gel column chromatography, and HPLC (High performance liquid chromatography) can be used.

また、例えば、得られた抽出物(または精製処理物、濃縮処理物、高活性画分)を、凍結乾燥処理に供して粉末化する方法、必要に応じてデキストリン、コーンスターチ、アラビアゴム等の賦形剤を添加して、スプレードライ処理により粉末化する方法等の従来公知の方法に従って粉末化し、本発明で用いる抽出物としてもよい。また、該抽出物を、必要に応じて純水、エタノール等に溶解して用いてもよい。 Further, for example, a method of pulverizing the obtained extract (or purified product, concentrated product, highly active fraction) by subjecting it to freeze-drying treatment, and if necessary, addition of dextrin, cornstarch, Arabic rubber, etc. The extract may be used in the present invention by adding a shaping agent and pulverizing according to a conventionally known method such as a method of pulverizing by spray-drying. Further, the extract may be used by dissolving it in pure water, ethanol or the like, if necessary.

前記植物の抽出物として好ましくは、原料となる植物を乾燥、破砕及び/または裁断し、好適な溶媒を使用して抽出、ろ過して得られる抽出物、また、このようにして得られる抽出物を更に乾燥させることにより得られる抽出物が例示される。 The extract of the plant is preferably an extract obtained by drying, crushing and / or cutting the plant as a raw material, extracting and filtering using a suitable solvent, and an extract thus obtained. An example is an extract obtained by further drying the mixture.

なお、本発明において、このように溶媒抽出を経て得た抽出物を特に溶媒抽出物と称することができる。また、本発明を制限するものではないが、前述のように例えば溶媒として水を用いた場合は水抽出物、低級アルコール類を用いた場合は低級アルコール抽出物、エタノールを用いた場合はエタノール抽出物等と称することができる。 In the present invention, the extract obtained through solvent extraction in this way can be particularly referred to as a solvent extract. Further, although not limiting the present invention, as described above, for example, when water is used as a solvent, a water extract is used, when lower alcohols are used, a lower alcohol extract is used, and when ethanol is used, an ethanol extract is used. It can be called a thing or the like.

本発明を制限するものではないが、一例として抽出物は次のようにして得ることができる。また、別の例として、抽出物は後述の実施例の手順に従って得ることができる。また、本発明において使用する抽出物は市販品でもよく、市販品に対して更に乾燥等の処理を適宜施したものでもよい。 Although not limiting the present invention, as an example, an extract can be obtained as follows. In addition, as another example, the extract can be obtained according to the procedure of Examples described later. Further, the extract used in the present invention may be a commercially available product, or may be a commercially available product that has been further subjected to a treatment such as drying.

本発明において抽出物は、前記植物を100gあたり、好ましくは前記植物の乾燥物、破砕物及び/または裁断物を100gあたり、抽出溶媒1〜50リットルに浸漬させて、任意の温度(例えば15〜90℃)で、必要に応じて攪拌しながら、任意の時間(例えば10分〜24時間)抽出を行い、次いで濾過することにより得ることができる。 In the present invention, the extract is obtained by immersing the plant in 100 g per 100 g, preferably a dried product, a crushed product and / or a cut product of the plant in 1 to 50 liters of an extraction solvent at an arbitrary temperature (for example, 15 to 15 to 15 to 50 liters). It can be obtained by extracting at 90 ° C.) for any time (eg, 10 minutes to 24 hours) with stirring as needed, and then filtering.

本発明を制限するものではないが、抽出溶媒として含水エタノールを用いた場合の具体的な一例を次に挙げる。本発明では、含水エタノールだけでなく、前述の抽出溶媒も同様に使用できる。 Although not limiting the present invention, a specific example when hydrous ethanol is used as the extraction solvent will be given below. In the present invention, not only hydrous ethanol but also the above-mentioned extraction solvent can be used in the same manner.

センキュウの抽出物は、センキュウ(好ましくは乾燥させて細切したもの、より好ましくは根茎)を100gあたり、含水エタノール(例えば好ましくは5〜99.5容量%エタノール、より好ましくは30〜99.5容量%エタノール)1〜50リットルに浸漬させて、例えば室温(15℃)〜80℃で、必要に応じて攪拌しながら、10分〜24時間抽出を行い、次いで濾過することにより得ることができる。 The extract of senkyu is a hydrous ethanol (for example, preferably 5 to 99.5% by volume ethanol, more preferably 30 to 99.5) per 100 g of senkyu (preferably dried and chopped, more preferably rhizome). It can be obtained by immersing in 1 to 50 liters of% ethanol), extracting at room temperature (15 ° C.) to 80 ° C. for 10 minutes to 24 hours with stirring as necessary, and then filtering. ..

クララの抽出物は、クララ(好ましくは乾燥させて細切したもの、より好ましくはクララの根)を100gあたり、含水エタノール(例えば好ましくは5〜99.5容量%エタノール、より好ましくは30〜99.5容量%エタノール)1〜50リットルに浸漬させて、例えば室温〜80℃で、必要に応じて攪拌しながら、10分〜24時間抽出を行い、次いで濾過することにより得ることができる。 The Clara extract is a hydrous ethanol (eg, preferably 5-99.5% by volume ethanol, more preferably 30-99) per 100 g of Clara (preferably dried and chopped, more preferably Clara root). It can be obtained by immersing in 1 to 50 liters of (5.5% by volume ethanol), extracting at room temperature to 80 ° C. for 10 minutes to 24 hours with stirring as necessary, and then filtering.

フキタンポポの抽出物、フユボダイジュの抽出物、ブクリョウの抽出物、ラベンダーの抽出物についても同様に説明でき、フキタンポポ(好ましくは乾燥させて細切したもの、より好ましくは花をそのまままたは周皮の大部分を除いたもの)、フユボダイジュ(好ましくは乾燥させて細切したもの、より好ましくは葉または花)、ブクリョウ(好ましくは乾燥させて細切したもの、より好ましくは外層をほとんど除いた菌核)、またはラベンダー(好ましくは乾燥させて細切したもの、より好ましくは花)を100gあたり、前述と同様に含水エタノール(例えば好ましくは5〜99.5容量%エタノール、より好ましくは30〜99.5容量%エタノール)1〜50リットルに浸漬させて、例えば室温〜80℃で、必要に応じて攪拌しながら、10分〜24時間抽出を行い、次いで濾過することにより得ることができる。 The same can be said for the extract of Tilia cordata, the extract of Tilia cordata, the extract of Bukuryo, and the extract of lavender. Tilia cordata (preferably dried and shredded, more preferably leaves or flowers), Bukuryo (preferably dried and shredded, more preferably mycelia with most of the outer layer removed) ), Or lavender (preferably dried and shredded, more preferably flowers) per 100 g, hydrous ethanol (eg preferably 5-99.5% by volume ethanol, more preferably 30-99. It can be obtained by immersing in 1 to 50 liters of 5% by volume ethanol), extracting at room temperature to 80 ° C. for 10 minutes to 24 hours with stirring as necessary, and then filtering.

これらについても前述のように1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 As described above, these may be used alone or in combination of two or more.

本発明の皮脂分泌促進剤中の前記抽出物の含有量は、本発明の効果が得られる限り制限されない。本発明を制限するものではないが、皮脂分泌促進剤中、例えば、抽出物は、抽出物の乾燥物換算で0.001〜100重量%、好ましくは0.01〜70重量%、より好ましくは0.1〜50重量%が例示される。前記抽出物を2種以上用いる場合、その合計量が該値を充足する。抽出物の乾燥物は抽出物を凍結乾燥処理することにより得られる。凍結乾燥処理は、一般的なエバポレーターを用いた減圧濃縮及び真空状態での凍結乾燥により行う。 The content of the extract in the sebum secretion promoter of the present invention is not limited as long as the effect of the present invention is obtained. Although not limiting the present invention, in the sebum secretion promoter, for example, the extract is 0.001 to 100% by weight, preferably 0.01 to 70% by weight, more preferably in terms of dry matter of the extract. 0.1 to 50% by weight is exemplified. When two or more kinds of the extracts are used, the total amount satisfies the value. The dried extract is obtained by freeze-drying the extract. The freeze-drying treatment is carried out by concentration under reduced pressure using a general evaporator and freeze-drying in a vacuum state.

本発明の皮脂分泌促進剤は前記抽出物のみを含有していてもよいが、前記抽出物以外に、本発明の効果を損なわない範囲で更に必要に応じて、溶剤(水、メタノール、エタノール等の低級アルコール、プロピレングリコール、1,3−ブチレングリコール等の多価アルコール等のアルコール類(無水、含水の別を問わない)等)、賦形剤、安定化剤、防腐剤、増粘剤、乳化剤、界面活性剤、結合剤、滑沢剤、吸収促進剤、油分、酸化防止剤、抗炎症剤、清涼剤、保湿剤、キレート剤、皮膜形成剤、pH調整剤、可溶化剤、香料、着色料等の任意の成分を含有してもよい。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 The preservative of the present invention may contain only the above-mentioned extract, but in addition to the above-mentioned extract, if necessary, a solvent (water, methanol, ethanol, etc.) is used as long as the effect of the present invention is not impaired. Lower alcohols, alcohols such as polyhydric alcohols such as propylene glycol, 1,3-butylene glycol (whether anhydrous or water-containing), excipients, stabilizers, preservatives, thickeners, etc. Emulsifiers, surfactants, binders, lubricants, absorption promoters, oils, antioxidants, anti-inflammatory agents, refreshing agents, moisturizers, chelating agents, film-forming agents, pH adjusters, solubilizers, fragrances, It may contain any component such as a colorant. These may be used individually by 1 type, and may be used in combination of 2 or more type.

また、本発明の皮脂分泌促進剤の形態も制限されず、液状、ペースト状、ムース状、乳液状、懸濁液状、クリーム状、軟膏状、ゲル状、固形状(粉末状、顆粒状等を含む)、シート状、エアゾール状、スプレー状、気泡状、貼付剤、リニメント剤、カプセル剤等の各種所望の液状、半固形状、固形状の形態等が例示される。前記任意の成分は、目的とする形態に合わせて適宜選択すればよく、また、各形態に応じた従来公知の方法に従って、前記抽出物及び必要に応じて任意の成分を用いて混合することにより、本発明の皮脂分泌促進剤を製造できる。 Further, the form of the sebaceous secretion promoter of the present invention is not limited, and liquid, paste, mousse, milky liquid, suspension, cream, ointment, gel, solid (powder, granular, etc.) can be used. Included), sheet-like, aerosol-like, spray-like, bubble-like, patch, liniment, capsule and other various desired liquid, semi-solid, solid forms and the like are exemplified. The arbitrary component may be appropriately selected according to the desired form, and by mixing with the extract and, if necessary, any component according to a conventionally known method corresponding to each form. , The sebum secretion promoter of the present invention can be produced.

本発明によれば皮脂分泌を促進できる。特に、後述の実施例から明らかなように、本発明によれば、細胞に直接作用して、皮脂腺からの皮脂分泌を促進できる。このことから、本発明によれば、皮脂分泌の低下に伴う各種皮膚症状を予防または改善できる。
皮脂分泌促進用外用組成物
本発明は、前記皮脂分泌促進剤を含有する皮脂分泌促進用外用組成物を提供する。
According to the present invention, sebum secretion can be promoted. In particular, as will be clear from the examples described later, according to the present invention, it is possible to directly act on cells and promote sebum secretion from the sebaceous glands. From this, according to the present invention, various skin symptoms associated with a decrease in sebum secretion can be prevented or ameliorated.
External Composition for Promoting Sebum Secretion The present invention provides an external composition for promoting sebum secretion containing the sebum secretion promoting agent.

該皮脂分泌促進剤は前述の通りである。本発明の皮脂分泌促進用外用組成物は、皮膚に外用形態で適用できる組成物である限り、その形態は制限されない。 The sebum secretion promoter is as described above. The form of the external composition for promoting sebum secretion of the present invention is not limited as long as it is a composition that can be applied to the skin in an external form.

該形態として、本発明を制限するものではないが、液状、ペースト状、ムース状、乳液状、懸濁液状、クリーム状、軟膏状、ゲル状、固形状(粉末状、顆粒状等を含む)、シート状、エアゾール状、スプレー状、気泡状、貼付剤、リニメント剤、カプセル剤等の各種所望の液状、半固形状、固形状の形態等が例示される。 The form is not limited to the present invention, but is liquid, paste, mousse, milky, suspension, cream, ointment, gel, solid (including powder, granular, etc.). , Sheet-like, aerosol-like, spray-like, bubble-like, patch, liniment, capsule and the like, various desired liquid, semi-solid, solid forms and the like are exemplified.

また、本発明の皮脂分泌促進用外用組成物の用途としては、本発明を制限するものではないが、化粧水、美容液、乳液、クリーム、ローション、パック、オイル、マッサージクリーム、洗顔クリーム、洗顔ジェル、石鹸、メイク落としクレンジング、ボディーウォッシュ、シャンプー、リンス、トリートメント、育毛剤、養毛剤、ヘアトニック、化粧下地、アイクリーム、ファンデーション、サンスクリーン、日焼け化粧料、チーク、アイシャドウ、アイライナー、口紅、グロス、リップクリーム、浴用剤等をはじめとする各種の化粧料、外用医薬部外品、外用医薬品などが挙げられる。これらは、当業界の通常の方法に従って調製される。 The use of the external composition for promoting sebum secretion of the present invention is not limited to the present invention, but is not limited to the present invention, but is not limited to the present invention. Gel, soap, makeup remover cleansing, body wash, shampoo, rinse, treatment, hair restorer, hair restorer, hair tonic, makeup base, eye cream, foundation, sunscreen, tanning cosmetics, teak, eye shadow, eyeliner, lipstick, Examples include various cosmetics such as gloss, lip balm, and bathing agents, external pharmaceutical products, and external pharmaceuticals. These are prepared according to the usual methods in the art.

本発明の皮脂分泌促進用外用組成物には、前述の皮脂分泌促進剤に加えて、必要に応じて薬学的または香粧品科学的に許容可能な任意の他の成分を更に配合することができる。他の成分としては、溶剤、賦形剤、安定化剤、防腐剤、増粘剤、乳化剤、界面活性剤、結合剤、吸収促進剤、油分、酸化防止剤、抗炎症剤、清涼剤、保湿剤、美白剤、抗アレルギー剤、損傷治療剤、キレート剤、皮膜形成剤、pH調整剤、可溶化剤、ゲル化剤、軟膏基剤、浸透促進剤、香料、着色料、アミノ酸、ビタミン、酵素、各種皮膚栄養成剤、紫外線吸収剤、紫外線散乱剤、皮膚保護剤等が例示される。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。また、これらは前記各種形態や用途に応じて、当業界の通常の方法に従い適宜選択すればよい。また、各形態に応じた従来公知の方法に従って、前記抽出物及び必要に応じて任意の成分を混合することにより、本発明の皮脂分泌促進用外用組成物を製造できる。 In addition to the above-mentioned sebum secretion-promoting agent, the external composition for promoting sebum secretion of the present invention may further contain any other pharmaceutically or cosmetically acceptable component, if necessary. .. Other ingredients include solvents, excipients, stabilizers, preservatives, thickeners, emulsifiers, surfactants, binders, absorption promoters, oils, antioxidants, anti-inflammatory agents, refreshing agents, moisturizers. Agents, whitening agents, antiallergic agents, damage treatment agents, chelating agents, film forming agents, pH adjusters, solubilizers, gelling agents, ointment bases, penetration enhancers, fragrances, coloring agents, amino acids, vitamins, enzymes , Various skin nutrients, UV absorbers, UV scatterers, skin protectants and the like are exemplified. These may be used individually by 1 type, and may be used in combination of 2 or more type. In addition, these may be appropriately selected according to the usual methods in the art according to the various forms and uses. In addition, the external composition for promoting sebum secretion of the present invention can be produced by mixing the extract and, if necessary, any component according to a conventionally known method according to each form.

本発明の皮脂分泌促進用外用組成物への前記皮脂分泌促進剤の含有量は、本発明の効果が奏される限り制限されないが、例えば、該組成物中、前記抽出物が、抽出物の乾燥物換算で0.0001〜20重量%、好ましくは0.001〜10重量%が例示される。前述と同様に、抽出物の乾燥物は抽出物を凍結乾燥処理したものを意味する。 The content of the sebum secretion-promoting agent in the external composition for promoting sebum secretion of the present invention is not limited as long as the effect of the present invention is exhibited. For example, in the composition, the extract is an extract. 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, in terms of dry matter is exemplified. As described above, the dried extract means the extract that has been freeze-dried.

本発明によれば、該皮脂分泌促進用外用組成物を皮膚に適用することによって、皮脂腺からの皮脂分泌を促進できる。特に、後述の実施例から明らかなように、本発明によれば、細胞に直接作用して、皮脂腺からの皮脂分泌を促進できる。このことから、本発明によれば、皮脂分泌の低下に伴う各種皮膚症状を予防または改善できる。 According to the present invention, by applying the external composition for promoting sebum secretion to the skin, sebum secretion from the sebaceous glands can be promoted. In particular, as will be clear from the examples described later, according to the present invention, it is possible to directly act on cells and promote sebum secretion from the sebaceous glands. From this, according to the present invention, various skin symptoms associated with a decrease in sebum secretion can be prevented or ameliorated.

本発明の皮脂分泌促進用外用組成物は、皮膚に適用することによって使用される。該組成物を適用する量ならびに回数については、特に制限されない。例えば、配合される成分の種類や濃度、使用者の年齢、性別、症状の程度、適用形態、期待される程度などに応じて、一日に一回若しくは数回の頻度で適当量を、全身の皮膚や所望の皮膚に部分的に適用すればよい。 The external composition for promoting sebum secretion of the present invention is used by applying it to the skin. The amount and number of times the composition is applied are not particularly limited. For example, depending on the type and concentration of the ingredients to be blended, the age, gender, degree of symptoms, application form, expected degree, etc. of the user, an appropriate amount may be applied to the whole body once or several times a day. It may be partially applied to the skin of the skin or the desired skin.

以下、実施例を示して本発明をより詳細に説明するが、本発明はこれらに限定されない。
1.抽出物等の調製
以下の手順に従い、各種植物の抽出物等を調製した。
Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
1. 1. Preparation of extracts, etc. Extracts, etc. of various plants were prepared according to the following procedure.

センキュウの抽出物に関して、市販のセンキュウ抽出物(商品名センキュウ抽出液−JC、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物3.1gを得た。次いで、DMSO(Dimethyl sulfoxide)に、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、センキュウ抽出物含有組成物を得た。 Regarding the extract of Senkyu, 100 g of a commercially available Senkyu extract (trade name: Senkyu Extract-JC, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then frozen in a vacuum state for 15 hours. Drying was carried out to obtain 3.1 g of a solid powder. Next, the extract (powder solid) obtained as described above was dissolved in DMSO (Dimethyl sulfoxide) to a concentration of 10, 100, 200 μg / μL to obtain a Senkyu extract-containing composition.

クララの抽出物に関して、市販のクララ抽出物(商品名クジン抽出液AL−J、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物1.4gを得た。次いで、DMSOに、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、クララ抽出物含有組成物を得た。 Regarding Clara extract, 100 g of commercially available Clara extract (trade name: Kujin extract AL-J, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then in a vacuum state for 15 hours. Freeze-drying was carried out to obtain 1.4 g of a solid powder. Next, the extract (powder solid) obtained as described above was dissolved in DMSO to 10, 100, 200 μg / μL to obtain a Clara extract-containing composition.

フキタンポポの抽出物に関して、市販のフキタンポポ抽出物(商品名フキタンポポ抽出液、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物2gを得た。次いで、DMSOに、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、フキタンポポ抽出物含有組成物を得た。 Regarding the coltsfoot extract, 100 g of a commercially available coltsfoot extract (trade name: coltsfoot extract, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then freeze-dried in a vacuum state for 15 hours. This was carried out to obtain 2 g of a solid powder. Next, the extract (powder solid) obtained as described above was dissolved in DMSO to 10, 100, 200 μg / μL to obtain a coltsfoot extract-containing composition.

フユボダイジュの抽出物に関して、市販のフユボダイジュ抽出物(商品名シナノキ抽出液、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物1.4gを得た。次いで、DMSOに、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、フユボダイジュ抽出物含有組成物を得た。 Regarding the extract of Tilia cordata, 100 g of a commercially available Tilia cordata extract (trade name: linden extract, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then frozen in a vacuum for 15 hours. Drying was carried out to obtain 1.4 g of a powder solid. Next, the extract (powder solid) obtained as described above was dissolved in DMSO to 10, 100, 200 μg / μL to obtain a Tilia cordata extract-containing composition.

ブクリョウの抽出物に関して、市販のブクリョウ抽出物(商品名ブクリョウ抽出液、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物0.4gを得た。次いで、DMSOに、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、ブクリョウ抽出物含有組成物を得た。 Regarding the Bukuryo extract, 100 g of a commercially available Bukuryo extract (trade name: Bukuryo extract, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then freeze-dried in a vacuum state for 15 hours. This was carried out to obtain 0.4 g of a solid powder. Next, the extract (powder solid) obtained as described above was dissolved in DMSO to 10, 100, 200 μg / μL to obtain a Bukuryo extract-containing composition.

ラベンダーの抽出物に関して、市販のラベンダー抽出物(商品名ラベンダー抽出液、ラベンダー抽出液LA−J、丸善製薬社製)100gを、エバポレーターを用いて30分間減圧濃縮してエタノールを除去した後、真空状態で15時間凍結乾燥を行い、粉末固形物4gを得た。次いで、DMSOに、前述のようにして得た抽出物(粉末固形物)を10、100、200μg/μLになるように溶かして、ラベンダー抽出物含有組成物を得た。
2.皮脂分泌促進活性評価
・ハムスター脂腺細胞の培養
正常ハムスター皮脂腺細胞(商品名:凍結Ha−SE(製品番号:KB−4009)、倉敷紡績社より購入)を解凍し、細胞数約10,000cells/cmとなるよう培養容器へ播種し、インキュベーター(37℃、5%CO)でほぼ密集(confluent)になるまで培養した。細胞培養には、hEGF(human Epidermal Growth Factor)(10ng/ml)、ウシ胎児血清(FBS)(8%V/V)、ヒト血清(HS)(2%V/V)を添加した皮脂腺細胞増殖用培地(製品名:HuMedia−BG(製品番号:KB−2150S)、倉敷紡績社より購入)を使用し、2日間培養した。
Regarding the lavender extract, 100 g of a commercially available lavender extract (trade name: lavender extract, lavender extract LA-J, manufactured by Maruzen Pharmaceuticals Co., Ltd.) was concentrated under reduced pressure for 30 minutes using an evaporator to remove ethanol, and then vacuumed. Freeze-drying was carried out in this state for 15 hours to obtain 4 g of a solid powder. Next, the extract (powder solid) obtained as described above was dissolved in DMSO to 10, 100, 200 μg / μL to obtain a lavender extract-containing composition.
2. Evaluation of sebum secretion promoting activity
-Culture of hamster sebaceous gland cells Normal hamster sebaceous gland cells (trade name: frozen Ha-SE (product number: KB-4009), purchased from Kurabo Industries Ltd.) are thawed and cultured so that the number of cells is about 10,000 cells / cm 2. The cells were seeded in a container and cultured in an incubator (37 ° C., 5% CO 2 ) until they became almost confluent. For cell culture, sebaceous gland cell proliferation to which hEGF (human Epidermal Growth Factor) (10 ng / ml), fetal bovine serum (FBS) (8% V / V), and human serum (HS) (2% V / V) were added. The medium (product name: HuMedia-BG (product number: KB-2150S), purchased from Kurashiki Spinning Co., Ltd.) was used for culturing for 2 days.

次いで、増殖したハムスター皮脂線細胞をHEPES(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)緩衝液(倉敷紡績社より購入)で洗浄後、トリプシン/EDTA溶液(倉敷紡績社より購入)を用いて培養皿より剥離し、トリプシン中和液(倉敷紡績社より購入)で中和後、約25,000cells/cmの細胞数になるよう24ウエルプレートに播種し、1日置きに皮脂腺細胞増殖用培地(製品名:HuMedia−BG(製品番号:KB−2150S)500μlを交換しながら5日間培養した。
・抽出物の添加
前述のようにして調製した各組成物2μLを、ウシ胎児血清(FBS)(8%V/V)、ヒト血清(HS)(2%V/V)を添加した皮脂腺細胞分化誘導用培地(製品名:HuMedia−BD(製品番号:KB−2250S)、倉敷紡績社より購入)1998μLに添加し、合計2000μLとした。このようにして得た混合物500μLを、前述のプレートのウエルに添加し、37℃で17日間培養した。
Next, the proliferated hamster sebaceous filament cells were washed with HEPES (4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid) buffer (purchased from Kurashiki Spinning Co., Ltd.) and then used with trypsin / EDTA solution (purchased from Kurashiki Spinning Co., Ltd.). After peeling from the culture medium and neutralizing with trypsin neutralizing solution (purchased from Kurashiki Spinning Co., Ltd.), seed the cells on a 24-well plate so as to have a cell number of about 25,000 cells / cm 2 and proliferate sebaceous gland cells every other day. The cells were cultured for 5 days while exchanging 500 μl of the medium (product name: HuMedia-BG (product number: KB-2150S)).
-Addition of extract Sebaceous gland cell differentiation in which 2 μL of each composition prepared as described above was added with fetal bovine serum (FBS) (8% V / V) and human serum (HS) (2% V / V). The medium for induction (product name: HuMedia-BD (product number: KB-2250S), purchased from Kurabo Industries Ltd.) was added to 1998 μL to make a total of 2000 μL. 500 μL of the mixture thus obtained was added to the wells of the above-mentioned plates and cultured at 37 ° C. for 17 days.

ポジティブコントロールとして、DMSOにインシュリン(倉敷紡績社より購入)を10μg/μLになるように溶かして混合液を得て、次いで、得られた混合液2μLを、前述と同様に皮脂腺細胞分化誘導用培地1998μLに添加して得た混合物を、前記ウエルに添加し、培養した。ネガティブコントロールとして、DMSO2μLを、前述と同様に皮脂腺細胞分化誘導用培地1998μLに添加して得た混合物を、前記ウエルに添加し、培養した。
・細胞数の測定、脂質合成量の測定、及び脂質合成量の算出
前記培養後、使用説明書に従い、各ウエルに細胞数測定溶液(商品名:細胞数測定溶液WST−8、倉敷紡績社より購入)を添加し、37℃で30分間インキュベートした。次いで、上清0.2ml/ウエルを96ウエルプレートにそれぞれ移し、吸光度を吸光度測定器機(型番 GENios Spectra FLUOR plus、メーカー名 TEKAN、波長450nm)を用いて測定することにより、細胞数を測定した。テトラゾリウム塩の還元により生じたホルマザン産物を検出することによって細胞数を測定できる。
As a positive control, insulin (purchased from Kurabo Industries Ltd.) was dissolved in DMSO to 10 μg / μL to obtain a mixed solution, and then 2 μL of the obtained mixed solution was used as a medium for inducing sebaceous gland cell differentiation in the same manner as described above. The mixture obtained by adding to 1998 μL was added to the wells and cultured. As a negative control, a mixture obtained by adding 2 μL of DMSO to 1998 μL of a medium for inducing sebaceous gland cell differentiation in the same manner as described above was added to the wells and cultured.
-Measurement of cell number, measurement of lipid synthesis amount, and calculation of lipid synthesis amount After the above culture, according to the instruction manual, a cell number measurement solution (trade name: cell number measurement solution WST-8, Kurashiki Spinning Co., Ltd.) should be added to each well. (Purchased) was added and incubated at 37 ° C. for 30 minutes. Next, 0.2 ml / well of the supernatant was transferred to each 96-well plate, and the number of cells was measured by measuring the absorbance using an absorbance measuring device (model number GENios Spectra FLUOR plus, manufacturer name TEKAN, wavelength 450 nm). The number of cells can be measured by detecting the formazan product produced by the reduction of the tetrazolium salt.

脂質合成量については、脂質合成測定キット(商品名:脂質合成測定キットSE−3001、倉敷紡績社より購入)を用いて、使用説明書に従い、オイルレッドO染色を行った。具体的には、PBS(−)緩衝液で細胞を2回洗浄し、10%ホルマリン溶液を添加し、室温で10分間静置することで細胞を固定し、PBS(−)緩衝液で細胞を2回洗浄した。次いで、オイルレッドO溶液の溶媒である60%イソプロパノールをあらかじめ加え1分間室温で静置し、続いてオイルレッドO溶液を添加し、室温で30分間静置し、細胞を染色した。その後、60%イソプロパノールで2回細胞を洗浄し、100%イソパノールを添加し、室温で5分間浸透した後、上清0.2ml/ウエルを96ウエルプレートに移し、吸光度を吸光度測定器機(波長520nm)を用いて測定することにより、脂質合成量を測定した。 Regarding the amount of lipid synthesis, Oil Red O staining was performed using a lipid synthesis measurement kit (trade name: lipid synthesis measurement kit SE-3001, purchased from Kurabo Industries Ltd.) according to the instruction manual. Specifically, the cells were washed twice with PBS (-) buffer, 10% formalin solution was added, and the cells were fixed by allowing them to stand at room temperature for 10 minutes, and the cells were treated with PBS (-) buffer. Washed twice. Next, 60% isopropanol, which is a solvent of the Oil Red O solution, was added in advance and allowed to stand at room temperature for 1 minute, then the Oil Red O solution was added and allowed to stand at room temperature for 30 minutes to stain the cells. Then, the cells were washed twice with 60% isopropanol, 100% isopropanol was added, and after permeating at room temperature for 5 minutes, 0.2 ml / well of the supernatant was transferred to a 96-well plate, and the absorbance was measured by an absorbance measuring device (wavelength 520 nm). ) Was used to measure the amount of lipid synthesis.

下記の式に従って、細胞当たりの蓄積された脂質合成量を算出した。
脂質合成量=吸光度520nm(脂質合成量測定値)/吸光度450nm(細胞数測定値)
・結果
結果を図1に示す。図1から明らかなように、前述の抽出物において、濃度依存的に、皮脂産生量が増加した。
The amount of accumulated lipid synthesis per cell was calculated according to the following formula.
Lipid synthesis amount = absorbance 520 nm (measured value of lipid synthesis amount) / absorbance 450 nm (measured value of cell number)
-Results The results are shown in Fig. 1. As is clear from FIG. 1, in the above-mentioned extract, the amount of sebum produced increased in a concentration-dependent manner.

オイルレッドO染色は疎水性色素であり、脂質との親和性が高く、皮脂の主成分であるトリグリセリド、コレステロール等を染色する。また、皮脂線は全分泌である。更に、図1は、脂質量を細胞数で除した値を示していることから、細胞当たりの脂質量を示している。また、ネガティブコントロールの値を1とした場合、図1には示さないがポジティブコントロールでは細胞当たりの脂質量が有意に増加した。 Oil Red O stain is a hydrophobic dye, has a high affinity for lipids, and stains triglycerides, cholesterol, etc., which are the main components of sebum. The sebaceous glands are holocrine. Furthermore, FIG. 1 shows the amount of lipid per cell because it shows the value obtained by dividing the amount of lipid by the number of cells. When the value of the negative control was 1, although not shown in FIG. 1, the amount of lipid per cell was significantly increased in the positive control.

このことから、前記抽出物によって皮脂腺細胞中の脂肪滴が成長し、皮脂の分泌が促進されたことが実証された。 From this, it was demonstrated that the extract caused the growth of lipid droplets in sebaceous gland cells and promoted the secretion of sebum.

このことから、前記抽出物は皮脂分泌促進作用を有していることが確認された。
処方例
下記の処方例及び説明に従い、センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種の抽出物を含有する皮脂分泌促進用外用組成物を製造した。該抽出物を含有する皮脂分泌促進用外用組成物によれば、皮脂分泌を促進できる。
・化粧水
下記表1の組成に従い、各成分を混合することにより、化粧水を得た。
From this, it was confirmed that the extract has a sebum secretion promoting action.
Formulation Example According to the following formulation example and description, an external composition for promoting sebum secretion containing at least one extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and Lavender was produced. According to the external composition for promoting sebum secretion containing the extract, sebum secretion can be promoted.
-Toner Toner was obtained by mixing each component according to the composition shown in Table 1 below.

Figure 0006920787
Figure 0006920787

・乳液
下記表2の組成に従い各成分を混合、加熱することにより、80℃以上に加熱したA成分とB成分を得た。次いでA成分とB成分を撹拌混合し、これを50℃まで冷却した後、C成分を加えて更に撹拌混合して、乳液を得た。
Emulsion By mixing and heating each component according to the composition shown in Table 2 below, components A and B heated to 80 ° C. or higher were obtained. Next, the A component and the B component were stirred and mixed, cooled to 50 ° C., the C component was added, and the mixture was further stirred and mixed to obtain a milky lotion.

Figure 0006920787
Figure 0006920787

・クリーム
下記表3の組成に従い各成分を混合、加熱することにより、80℃以上に加熱したA成分とB成分を得た。次いでA成分とB成分を撹拌混合し、これを50℃まで冷却した後、C成分を加えて更に撹拌混合して、クリームを得た。
-Cream By mixing and heating each component according to the composition shown in Table 3 below, components A and B heated to 80 ° C. or higher were obtained. Next, the A component and the B component were stirred and mixed, cooled to 50 ° C., the C component was added, and the mixture was further stirred and mixed to obtain a cream.

Figure 0006920787
Figure 0006920787

・ボディシャンプー
下記表4の組成に従い各成分を混合し、80℃に加温して均一に溶解したA成分とB成分を得た。次いでA成分にB成分を加えて撹拌混合しながら室温まで冷却した。これにC成分を加えてボディシャンプーを得た。
-Body shampoo Each component was mixed according to the composition shown in Table 4 below, and heated to 80 ° C. to obtain uniformly dissolved components A and B. Next, component B was added to component A, and the mixture was cooled to room temperature while stirring and mixing. A body shampoo was obtained by adding the C component to this.

Figure 0006920787
Figure 0006920787

・石けん
下記表5の組成に従い各成分を混合し、80℃に加温して均一に溶解したA成分とB成分を得た。次いでA成分にB成分を加えてケン化した。これを撹拌しながら50℃まで冷却し、これにC成分を加えた。これを型に流し込み冷却した後、室温で数日間乾燥させ、十分に乾燥したものを型から取り出して石けんを得た。
-Soap Each component was mixed according to the composition shown in Table 5 below, and heated to 80 ° C. to obtain uniformly dissolved components A and B. Then, the B component was added to the A component to saponify it. This was cooled to 50 ° C. with stirring, and the C component was added thereto. This was poured into a mold and cooled, and then dried at room temperature for several days, and a sufficiently dried product was taken out from the mold to obtain soap.

Figure 0006920787
Figure 0006920787

・アンチリンクルクリーム
下記表6の組成に従い各成分を混合し、80℃に加温して均一に溶解したA成分とB成分を得た。次いで、A成分をホモミキサーで攪拌しながら、B成分を徐々に加えて乳化した。これをパドル攪拌しながら冷却し、50〜35℃でC成分を加えて攪拌し、アンチリンクルクリームを得た。
-Anti-wrinkle cream Each component was mixed according to the composition shown in Table 6 below, and heated to 80 ° C. to obtain components A and B uniformly dissolved. Then, while stirring the component A with a homomixer, the component B was gradually added and emulsified. This was cooled with paddle stirring, and the C component was added and stirred at 50 to 35 ° C. to obtain an anti-wrinkle cream.

Figure 0006920787
Figure 0006920787

・サンスクリーンクリーム
下記表7の組成に従い各成分を混合し、80℃に加温して均一に溶解したA成分とB成分を得た。次いで、B成分をホモミキサーで攪拌しながら、A成分を徐々に加えて乳化した。これをパドル攪拌しながら冷却し、50℃前後でC成分を加え、35〜30℃で攪拌を止めて、サンスクリーンクリームを得た。
-Sunscreen cream Each component was mixed according to the composition shown in Table 7 below, and heated to 80 ° C. to obtain uniformly dissolved components A and B. Then, while stirring the B component with a homomixer, the A component was gradually added and emulsified. This was cooled with paddle stirring, the C component was added at around 50 ° C., and the stirring was stopped at 35 to 30 ° C. to obtain a sunscreen cream.

Figure 0006920787
Figure 0006920787

・美容液
下記表8の組成に従い各成分を混合して、A〜D成分をそれぞれ室温で溶解し、A成分を攪拌しながら、B成分を徐々に加えて粘稠性液体とし、次いでC、D成分を加えて均一にして、美容液を得た。
Essence: Mix each component according to the composition shown in Table 8 below, dissolve components A to D at room temperature, and gradually add component B while stirring component A to make a viscous liquid, and then C, The D component was added and homogenized to obtain a beauty essence.

Figure 0006920787
Figure 0006920787

・ファンデーション
下記表9の組成に従い、A成分とB成分を80℃で混合し、A成分を攪拌しながらB成分を徐々に加えて乳化した。次いで、攪拌しながら冷却し、50℃でC成分を加え、40〜35℃で攪拌を止めて、ファンデーションを得た。
-Foundation According to the composition shown in Table 9 below, the A component and the B component were mixed at 80 ° C., and the B component was gradually added while stirring the A component for emulsification. Then, the mixture was cooled with stirring, the C component was added at 50 ° C., and the stirring was stopped at 40 to 35 ° C. to obtain a foundation.

Figure 0006920787
Figure 0006920787

・シャンプー
下記表10の組成に従い、A成分とB成分を70℃で加熱溶解し、A成分にB成分を加えて攪拌して混合した。次いで、攪拌しながら冷却し、50℃以下でC成分を加え、40〜35℃で攪拌を止めて、シャンプーを得た。
-Shampoo According to the composition shown in Table 10 below, the A component and the B component were heated and dissolved at 70 ° C., the B component was added to the A component, and the mixture was stirred and mixed. Then, the mixture was cooled with stirring, the C component was added at 50 ° C. or lower, and the stirring was stopped at 40 to 35 ° C. to obtain a shampoo.

Figure 0006920787
Figure 0006920787

・リンス
下記表11の組成に従い、A成分とB成分を80℃で加熱溶解し、A成分を攪拌しながらB成分を徐々に加えて乳化した。次いで、攪拌しながら冷却し、50℃以下でC成分を加え、40〜35℃で攪拌を止めて、リンスを得た。
-Rinse According to the composition shown in Table 11 below, the A component and the B component were heated and dissolved at 80 ° C., and the B component was gradually added and emulsified while stirring the A component. Then, the mixture was cooled with stirring, the C component was added at 50 ° C. or lower, and the stirring was stopped at 40 to 35 ° C. to obtain a rinse.

Figure 0006920787
Figure 0006920787

・ヘアトリートメント
下記表12の組成に従い、A成分とB成分を80℃で加熱溶解し、B成分を攪拌しながらA成分を徐々に加えて乳化した。次いで、攪拌しながら冷却し、50℃以下でC成分を加え、40〜35℃で攪拌を止めて、ヘアトリートメントを得た。
-Hair Treatment According to the composition shown in Table 12 below, the A component and the B component were heated and dissolved at 80 ° C., and the A component was gradually added and emulsified while stirring the B component. Then, the mixture was cooled with stirring, the C component was added at 50 ° C. or lower, and the stirring was stopped at 40 to 35 ° C. to obtain a hair treatment.

Figure 0006920787
Figure 0006920787

・ヘアリキッド
下記表13の組成に従い、A成分を室温で混合し、均一に溶解した。次いで、混合して得たB成分をA成分に攪拌しながら加えて均一にし、ヘアリキッドを得た。
-Hair Liquid According to the composition shown in Table 13 below, component A was mixed at room temperature and dissolved uniformly. Then, the B component obtained by mixing was added to the A component with stirring to make it uniform, and a hair liquid was obtained.

Figure 0006920787
Figure 0006920787

・ボディクリーム
下記表14の組成に従い、A成分とB成分を70℃で加熱溶解した。A成分をB成分に加えてホモミキサーで均一に分散し、攪拌しながら冷却した。40℃となった後にC成分を加えて、均一に攪拌しながら室温まで冷却し、ボディクリームを得た。
-Body cream According to the composition shown in Table 14 below, components A and B were heated and dissolved at 70 ° C. Component A was added to component B, dispersed uniformly with a homomixer, and cooled with stirring. After the temperature reached 40 ° C., component C was added and cooled to room temperature with uniform stirring to obtain a body cream.

Figure 0006920787
Figure 0006920787

・リップクリーム
下記表15の組成に従い、A成分を均一にプレミックスし、B成分に加えて均一に混合した。ここにC成分を加えてゆっくり攪拌しながら70〜80℃まで加熱し、D、E成分を少しずつ加えた。均一に攪拌し、型に流し入れ、リップクリームを得た。
-Lip balm According to the composition shown in Table 15 below, component A was uniformly premixed, and component B was added and mixed uniformly. The C component was added thereto, and the mixture was heated to 70 to 80 ° C. with gentle stirring, and the D and E components were added little by little. Stirred evenly and poured into a mold to obtain lip balm.

Figure 0006920787
Figure 0006920787

・クレンジングクリーム
下記表16の組成に従い、A成分、B成分をそれぞれ80℃で加熱溶解し、65℃に保った。A成分を攪拌しながらB成分を徐々に加え乳化した。これらを攪拌しながら冷却し、50℃以下でC成分を加えて、40〜30℃で攪拌を止め、クレンジングクリームを得た。
-Cleansing cream According to the composition shown in Table 16 below, components A and B were each heated and dissolved at 80 ° C. and maintained at 65 ° C. While stirring the A component, the B component was gradually added and emulsified. These were cooled with stirring, the C component was added at 50 ° C. or lower, and the stirring was stopped at 40 to 30 ° C. to obtain a cleansing cream.

Figure 0006920787
Figure 0006920787

・クレンジングオイル
下記表17の組成に従い、各成分を均一に混合して、クレンジングオイルを得た。
-Cleansing oil According to the composition shown in Table 17 below, each component was uniformly mixed to obtain a cleansing oil.

Figure 0006920787
Figure 0006920787

・洗顔フォーム
下記表18の組成に従い、A成分、B成分をそれぞれ80℃で加熱溶解する。C成分は室温で溶解する。A成分を撹拌しながらB成分を徐々に加えて均一溶解し、次いでC成分を加え均一にする。これらを攪拌しながら冷却し、35〜30℃で攪拌を止めて、洗顔フォームを得た。
Facial cleansing foam According to the composition shown in Table 18 below, component A and component B are each heated and dissolved at 80 ° C. The C component dissolves at room temperature. While stirring the A component, gradually add the B component to dissolve it uniformly, and then add the C component to make it uniform. These were cooled with stirring, and the stirring was stopped at 35 to 30 ° C. to obtain a facial cleansing foam.

Figure 0006920787
Figure 0006920787

・バスミルク
下記表19の組成に従い、A成分、B成分をそれぞれ70℃で加熱溶解する。A成分をホモミキサーでかき混ぜながらB成分を加えて乳化した。その後、パドルでかき混ぜながら30℃まで冷却し、バスミルクを得た
-Bath milk According to the composition shown in Table 19 below, the components A and B are each heated and dissolved at 70 ° C. While stirring component A with a homomixer, component B was added and emulsified. After that, it was cooled to 30 ° C. while stirring with a paddle to obtain bath milk.

Figure 0006920787
Figure 0006920787

・化粧水
下記表20の組成に従い、B成分を室温で混合し、そこにA成分を加えて撹拌混合し、化粧水を得た。
-Toner According to the composition shown in Table 20 below, component B was mixed at room temperature, component A was added thereto, and the mixture was stirred and mixed to obtain a lotion.

Figure 0006920787
Figure 0006920787

・美容液
下記表21の組成に従い、B成分及びC成分を撹拌混合し、D成分を加えてpH6に調整した。次いで、A成分を加えてホモミキサーで撹拌し、更に所定量のE成分を加えた後、均一にして美容液を得た。
-Beauty essence According to the composition shown in Table 21 below, the B component and the C component were stirred and mixed, and the D component was added to adjust the pH to 6. Next, component A was added and stirred with a homomixer, and a predetermined amount of component E was further added and then homogenized to obtain a beauty essence.

Figure 0006920787
Figure 0006920787

・クリーム
下記表22の組成に従い、A成分を80℃に加熱して混合した油相と、B成分を80℃に加熱して混合した水相をそれぞれ調製した後、それらを混合してホモミキサーで乳化した。40℃まで撹拌冷却した後に、所定量のC成分を添加し、更に30℃まで撹拌冷却することによりクリームを得た。
-Cream According to the composition shown in Table 22 below, an oil phase in which component A is heated to 80 ° C. and mixed, and an aqueous phase in which component B is heated to 80 ° C. and mixed are prepared, and then they are mixed and homomixed. Emulsified with. After stirring and cooling to 40 ° C., a predetermined amount of C component was added, and the mixture was further stirred and cooled to 30 ° C. to obtain a cream.

Figure 0006920787
Figure 0006920787

Claims (3)

センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種のアルコール抽出物を含有する皮脂分泌促進剤。 A sebum secretagogue containing at least one alcohol extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and lavender. 請求項1に記載する皮脂分泌促進剤を含有する、皮脂分泌の低下に伴う皮膚症状を予防又は改善するための、皮脂分泌促進用外用組成物。 An external composition for promoting sebum secretion, which contains the sebum secretion-promoting agent according to claim 1, for preventing or ameliorating skin symptoms associated with a decrease in sebum secretion. 前記組成物中、センキュウ、クララ、フキタンポポ、フユボダイジュ、ブクリョウ及びラベンダーからなる群より選択される少なくとも1種のアルコール抽出物を、該抽出物の乾燥物換算で0.0001〜20重量%含有する、請求項2に記載の皮脂分泌促進用外用組成物。 In the composition, at least one alcohol extract selected from the group consisting of Senkyu, Clara, Coltsfoot, Tilia cordata, Bukuryo and lavender is contained in an amount of 0.0001 to 20% by weight in terms of a dried product of the extract. , The external composition for promoting sebum secretion according to claim 2.
JP2015195252A 2015-09-30 2015-09-30 Sebum secretion promoter and its use Active JP6920787B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2015195252A JP6920787B2 (en) 2015-09-30 2015-09-30 Sebum secretion promoter and its use
PCT/JP2016/078547 WO2017057420A1 (en) 2015-09-30 2016-09-27 Sebum secretion promoter and utilization thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015195252A JP6920787B2 (en) 2015-09-30 2015-09-30 Sebum secretion promoter and its use

Publications (2)

Publication Number Publication Date
JP2017066106A JP2017066106A (en) 2017-04-06
JP6920787B2 true JP6920787B2 (en) 2021-08-18

Family

ID=58423925

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015195252A Active JP6920787B2 (en) 2015-09-30 2015-09-30 Sebum secretion promoter and its use

Country Status (2)

Country Link
JP (1) JP6920787B2 (en)
WO (1) WO2017057420A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3816262B2 (en) * 1998-09-30 2006-08-30 花王株式会社 Ceramide production promoter
JP2003292432A (en) * 2002-04-04 2003-10-15 Noevir Co Ltd Skin care preparation
JP2003171310A (en) * 2002-05-02 2003-06-20 Noevir Co Ltd Skin barrier function-reinforcing agent
JP2004339113A (en) * 2003-05-14 2004-12-02 Ichimaru Pharcos Co Ltd Agent for preventing and ameliorating chapped skin by stress
KR20050110720A (en) * 2004-05-18 2005-11-23 주식회사 태평양 Cosmetic composition for moisturizing effect on the skin
JP5404985B2 (en) * 2004-11-12 2014-02-05 株式会社 資生堂 Fragrance composition for male hormone adjustment
JP2008007411A (en) * 2006-06-27 2008-01-17 Maruzen Pharmaceut Co Ltd Transglutaminase production promoter and epidermal keratinization normalizing agent
JP5717958B2 (en) * 2008-11-26 2015-05-13 株式会社コーセー Ceramide production promoter, and pharmaceutical composition, skin external preparation, cosmetic composition and cosmetic using the ceramide production promoter
JP2012036162A (en) * 2010-08-12 2012-02-23 Septem Soken:Kk Ceramide synthesis promoter and skin care preparation containing the same

Also Published As

Publication number Publication date
WO2017057420A1 (en) 2017-04-06
JP2017066106A (en) 2017-04-06

Similar Documents

Publication Publication Date Title
US8414933B2 (en) Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent
JP6389308B1 (en) Topical skin preparation
KR20230147028A (en) Composition for anti-aging, anti-inflammation or skin regeneration containing Cannabis sativa stem extract as effective component
JP2009234944A (en) Cosmetic composition containing vegetable extract
JP2015027998A (en) Moisturizer, skin barrier function activator, tight junction formation accelerator, trpv4 expression enhancer, intracellular calcium concentration increaser, intracellular calcium concentration increaser, lipid synthesis accelerator, blood flow improver and periocular darkness ameliorator
JP2009234942A (en) Cosmetic composition containing vegetable extract
JP2009234939A (en) Cosmetic composition containing vegetable origin polyamine-containing extract
JP4425163B2 (en) Anti-aging cosmetics
JP2020502172A (en) Cosmetic composition containing Chinese herbal extract as active ingredient
KR102214985B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
JP6338107B2 (en) Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, and TRPV4 gene expression enhancer
KR102300581B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
JP2009234943A (en) Cosmetic composition containing vegetable extract
FR2928549A1 (en) USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING
JP2009234940A (en) Cosmetic composition containing vegetable extract
JP2009234938A (en) Cosmetic composition containing vegetable origin polyamine-containing extract
JP6920787B2 (en) Sebum secretion promoter and its use
JP6732495B2 (en) Composition for suppressing sebum secretion
JP5462491B2 (en) Proanthocyanidin trimer
WO2023249046A1 (en) Agent for maintaining structure of hyaluronic acid
JP7589988B2 (en) Proteasome activators
CN105943414B (en) Cosmetic composition comprising cultured root oil of wild ginseng as active ingredient, method for preparing the same and cosmetic method using the same
KR20180131688A (en) Anti-aging cosmetic composition containing rehmanniae radix preparata, liriope platyphylla wang et tang, asparagus cochinchinensis and lithospermum erythorhizon extracts
JP2009234937A (en) Cosmetic composition containing vegetable origin polyamine-containing extract
CN118103041B (en) Preadipocyte proliferation and/or differentiation promoter containing helical lactone derivatives

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190723

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200901

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200901

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200929

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201006

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20201204

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20201208

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210511

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210622

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210720

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210720

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210727

R150 Certificate of patent or registration of utility model

Ref document number: 6920787

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250